Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip: Case report and literature review

Hematol Oncol Stem Cell Ther. 2021 Mar;14(1):76-81. doi: 10.1016/j.hemonc.2018.12.002. Epub 2018 Dec 31.

Abstract

Non-Hodgkin lymphoma (NHL) of the lip is extremely rare. It is usually indolent and in early stages a local approach is often indicated. We present a case report of a patient with extranodal NHL of the lip treated with chemotherapy and low-dose radiation treatment (RT). The patient was affected by B-cell NHL of the marginal zone, Stage IAE. After a few months of observation with progressive disease, the patient was submitted to two cycles of chemotherapy with no response. Therefore, he was treated with very low-dose RT consisting of two fractions of 2 Gy. Complete response was observed and after 1-year follow-up, persistent complete response was recorded. In cases of localized disease, especially in patients with comorbidities of poor performance status (PS), low-dose RT can be an appropriate approach with excellent outcomes in terms of effectiveness and low risk of toxicity.

Keywords: Extranodal marginal zone lymphoma; Lip lymphoma; Low-dose radiotherapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged, 80 and over
  • Humans
  • Lip Neoplasms / metabolism
  • Lip Neoplasms / pathology
  • Lip Neoplasms / radiotherapy*
  • Lymphoma, B-Cell, Marginal Zone / metabolism
  • Lymphoma, B-Cell, Marginal Zone / pathology
  • Lymphoma, B-Cell, Marginal Zone / radiotherapy*
  • Male
  • Radiotherapy Dosage